Comparison of gemcitabine plus platinum analogue with gemcitabine alone in advanced pancreatic cancer

Eileen O�Reilly and Ghassan Abou-Alfa

A pooled analysis of two randomised trials has shown that gemcitabine in combination with a platinumanalogue (cisplatin or oxaliplatin) is a potential front-line treatment option in advanced pancreatic adenocarcinoma.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.


*


UA-77507851-1